Health outcomes after myocardial infarction: A population study of 56 million people in England
Open Access
- 15 February 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 21 (2) , e1004343
Abstract
Background: The occurrence of a range of health outcomes following myocardial infarction (MI) is unknown. Therefore, this study aimed to determine the long-term risk of major health outcomes following MI and generate sociodemographic stratified risk charts in order to inform care recommendations in the post-MI period and underpin shared decision making. Methods and findings: This nationwide cohort study includes all individuals aged ≥18 years admitted to one of 229 National Health Service (NHS) Trusts in England between 1 January 2008 and 31 January 2017 (final follow-up 27 March 2017). We analysed 11 non-fatal health outcomes (subsequent MI and first hospitalisation for heart failure, atrial fibrillation, cerebrovascular disease, peripheral arterial disease, severe bleeding, renal failure, diabetes mellitus, dementia, depression, and cancer) and all-cause mortality. Of the 55,619,430 population of England, 34,116,257 individuals contributing to 145,912,852 hospitalisations were included (mean age 41.7 years (standard deviation [SD 26.1]); n = 14,747,198 (44.2%) male). There were 433,361 individuals with MI (mean age 67.4 years [SD 14.4)]; n = 283,742 (65.5%) male). Following MI, all-cause mortality was the most frequent event (adjusted cumulative incidence at 9 years 37.8% (95% confidence interval [CI] [37.6,37.9]), followed by heart failure (29.6%; 95% CI [29.4,29.7]), renal failure (27.2%; 95% CI [27.0,27.4]), atrial fibrillation (22.3%; 95% CI [22.2,22.5]), severe bleeding (19.0%; 95% CI [18.8,19.1]), diabetes (17.0%; 95% CI [16.9,17.1]), cancer (13.5%; 95% CI [13.3,13.6]), cerebrovascular disease (12.5%; 95% CI [12.4,12.7]), depression (8.9%; 95% CI [8.7,9.0]), dementia (7.8%; 95% CI [7.7,7.9]), subsequent MI (7.1%; 95% CI [7.0,7.2]), and peripheral arterial disease (6.5%; 95% CI [6.4,6.6]). Compared with a risk-set matched population of 2,001,310 individuals, first hospitalisation of all non-fatal health outcomes were increased after MI, except for dementia (adjusted hazard ratio [aHR] 1.01; 95% CI [0.99,1.02];p = 0.468) and cancer (aHR 0.56; 95% CI [0.56,0.57];p < 0.001). The study includes data from secondary care only—as such diagnoses made outside of secondary care may have been missed leading to the potential underestimation of the total burden of disease following MI. Conclusions: In this study, up to a third of patients with MI developed heart failure or renal failure, 7% had another MI, and 38% died within 9 years (compared with 35% deaths among matched individuals). The incidence of all health outcomes, except dementia and cancer, was higher than expected during the normal life course without MI following adjustment for age, sex, year, and socioeconomic deprivation. Efforts targeted to prevent or limit the accrual of chronic, multisystem disease states following MI are needed and should be guided by the demographic-specific risk charts derived in this study.Keywords
Funding Information
- Wellcome Trust (206470/Z/17/Z)
- British Heart Foundation (PG/19/54/34511)
- Alan Turing Institute (BHF-Turing-19/02/1022)
- Wellcome Trust (227498/Z/23/Z)
This publication has 67 references indexed in Scilit:
- Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020JAMA, 2023
- Aspirin Use to Prevent Cardiovascular DiseaseJAMA, 2022
- Predicting risk of cardiovascular events 1 to 3 years post‐myocardial infarction using a global registryClinical Cardiology, 2019
- Cardiovascular events and death after myocardial infarction or ischemic stroke in an older Medicare populationClinical Cardiology, 2019
- Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and PreferencesJAMA Cardiology, 2018
- Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial InfarctionJAMA Cardiology, 2017
- Heart Failure in Post-MI Patients With Persistent IRA Occlusion: Prevalence, Risk Factors, and the Long-Term Effect of PCI in the Occluded Artery Trial (OAT)Journal of Cardiac Failure, 2012
- Low-dose Aspirin and Cancer Mortality: A Meta-analysis of Randomized TrialsThe American Journal of Medicine, 2012
- Association Between Statin Use and the Incidence of Atrial Fibrillation Following Hospitalization for Coronary Artery DiseaseThe American Journal of Cardiology, 2010
- Risk-Set Matching2009